425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive planning to issue Class A common stock.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was reposted by Pierre Rochard, a Board Member of Strive, Inc., on September 30, 2025.
• Strive intends to file a Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, with the SEC.
• The Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders for approval of the proposed transaction.
• The filing includes extensive cautionary statements regarding forward-looking statements and associated risks.

Sentiment

Score: 6

Explanation: The filing announces a significant strategic move (merger) which is generally positive for growth, but it is heavily weighted with extensive and detailed risk disclosures, balancing the overall sentiment towards neutral-positive rather than strongly positive.

Positives

• Anticipated strategic benefits are expected from the proposed transaction.
• Expected financial benefits are projected from the proposed transaction.
• A positive impact on the combined company's future financial performance is anticipated.

Negatives

• The proposed transaction may be more difficult, time-consuming, or costly than expected.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Dilution for Strive shareholders is expected due to the issuance of additional Class A common stock.
• Potential for adverse reactions from Strive's or Semler Scientific's customers exists.
• Changes to business or employee relationships may result from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could be negative.

Risks

• The merger agreement could be terminated due to unforeseen events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if conditions to closing are not met on a timely basis.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks are associated with the implementation of Bitcoin treasury strategies and exposure to Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the combined entity.
• Integration of the two companies may prove more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities is a concern.
• Dilution will be caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from customers or changes to business or employee relationships could occur.
• Changes in Strive's or Semler Scientific's share price before closing are a risk.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, expecting a positive impact on the combined company's future financial performance. However, this outlook is subject to significant risks and uncertainties, including successful integration, general economic conditions, and market factors related to digital assets.

Management Comments

• "Certain statements herein and the documents incorporated herein by reference may constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Rule 175 promulgated thereunder, and Section 21E of the Exchange Act and Rule 3b-6 promulgated thereunder, which statements involve inherent risks and uncertainties."
• "Although each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that actual results of Strive or Semler Scientific will not differ materially from any projected future results expressed or implied by such forward-looking statements."

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the combined entity may have significant exposure to or plans involving the cryptocurrency market. This aligns with a broader trend of companies exploring digital assets for treasury management or strategic investments, indicating a potential shift or expansion into this evolving sector.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of new Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employees of both companies may experience changes to their business or employment relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Investment